This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD HANDELSMAN, MD
Department of Pediatrics Schneider Children's Hospital Long Island Jewish Medical Center New Hyde Park, NY 11042

DEBRA VOULALAS, MD
Children's Seashore House Children's Hospital of Philadelphia Philadelphia, Pa

Am J Dis Child. 1991;145(6):603-604.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—Recently we treated a 12-year-old boy with sickle cell anemia and acute chest syndrome (ACS) who had decreased air entry in the same way an asthmatic patient does. This prompted us to treat him with nebulized albuterol, which improved his dyspnea and aeration. Finding no reports of β2 agonist use in acute chest syndrome we performed the following preliminary study to determine if albuterol inhalation therapy could be a useful adjunct in the treatment of ACS in sickle cell anemia.

Patient Reports.—Four patients, including the aforementioned one, all with ACS and sickle cell anemia, were evaluated. None had a personal or family history of asthma or wheezing. Each was at least 8 years old, enabling use of the Wright peak flow meter. Initially each patient had chest pain, difficulty breathing, decreased breath sounds and/or crackles on chest auscultation, and roentgenographic evidence of an acute pulmonary infiltrate. Each was . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?